Circumvention of Multidrug Resistance in Genitourinary Tumors

This publication has 70 references indexed in Scilit:

• Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers
  European Journal Of Cancer, 1996
• Reversal of Chemoresistance of Lymphoma Cells by Antisense-Mediated Reduction ofbcl-2 Gene Expression
  Antisense Research and Development, 1994
• Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
  Cell, 1993
• Biochemistry of Multidrug Resistance Mediated by the Multidrug Transporter
  Annual Review of Biochemistry, 1993
• Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
  Science, 1992
• Increased Effectiveness of Liposome-Encapsulated Doxorubicin in Multidrug-Resistant-Transgenic Mice Compared With Free Doxorubicin
  JNCI Journal of the National Cancer Institute, 1992
• Reversal of Drug Resistance in a Human Colon Cancer Xenograft Expressing MDR1 Complementary DNA by In Vivo Administration of MRK-16 Monoclonal Antibody
  JNCI Journal of the National Cancer Institute, 1991
• Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance.
  Proceedings of the National Academy of Sciences, 1991
• Mechanisms of multidrug resistance in human tumor cells. The roles of P-glycoprotein, DNA topoisomerase II, and other factors
  Cancer Treatment Reviews, 1990
• MDR1 RNA Levels in Human Renal Cell Carcinomas: Correlation With Grade and Prediction of Reversal of Doxorubicin Resistance by Quinidine in Tumor Explants
  JNCI Journal of the National Cancer Institute, 1989